You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 15, 2025

PTAB Cases by Type: Inter partes review


✉ Email this page to a colleague

« Back to Dashboard


Patent Trial and Appeal Board Cases by Type: Inter partes review

Glossary
PatentPetitionerStatusFiling DateAccorded Filing DatePatent OwnerTrial TypeTrial NumberDecision DateInventorDocument Download
7,772,209 Accord Healthcare, Inc., USA ⤷  Try for Free 2013-06-14 06-14-2013 Eli Lilly and Company Inter partes review ⤷  Try for Free 10-01-2013 Clet Niyikiza ⤷  Try for Free
8,212,094 Syntroleum Corporation ⤷  Try for Free 2013-03-08 03-08-2013 Neste Oil OYJ Inter partes review ⤷  Try for Free 09-04-2013 Jukka MYLLYOJA ⤷  Try for Free
6,436,989 Ranbaxy Laboratories Ltd. et al. ⤷  Try for Free 2012-10-18 10-18-2012 Vertex Pharmaceuticals Incorporated Inter partes review ⤷  Try for Free 03-05-2013 MICHAEL HALE ⤷  Try for Free
7,671,070 Apotex Inc. ⤷  Try for Free 2012-10-12 10-12-2012 Alcon Inter partes review ⤷  Try for Free 03-19-2013 Gerald Cagle ⤷  Try for Free
6,716,830 Apotex Inc. ⤷  Try for Free 2012-10-05 10-04-2012 Alcon Pharmaceuticals Ltd. Inter partes review ⤷  Try for Free 03-19-2013 Gerald Cagle ⤷  Try for Free
>Patent>Petitioner>Status>Filing Date>Accorded Filing Date>Patent Owner>Trial Type>Trial Number>Decision Date>Inventor>Document Download

Subscribe to access the full database, or Try for Free

Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group